Document is current
Any future updates will be listed below
-
Authors
Vieilledent, Léa
Gaujard, Sylvain
Gossez, Morgane
Broyer, Anne
Bodinier, Maxime
Goff, Samuel Le
Di-Valentin, Karine
Renaud, Elisa
Dumay, Constance
Foray, Anne-Perrine
Monneret, Guillaume
Venet, Fabienne
-
Funding
Funding for this research was provided by:
LV is the recipient of a research grant (“année recherche”) from Hospices Civils de Lyon.
This work was supported by intramural grant from EA7426 (Lyon 1 University) and Immunology Department (Hospices Civils de Lyon).
- License Information
-
More Information
Article History
Received: 26 September 2025
Accepted: 24 March 2026
First Online: 17 April 2026
Declarations
:
: MB is an employee of bioMérieux. The other authors declare no conflicts of interest.
: The study was registered at clinicaltrials.gov (NCT06513520). The protocol was developed in collaboration with the Ageing-Brain-Frailty Clinical Research Center (Hospices Civils de Lyon, France). Informed consent or documented non-opposition to participation was systematically obtained from the patient or a legal representative before any blood sample collection and recorded in the patient’s clinical file. All procedures complied with the ethical standards of the institutional and national research committees (CPP Ouest IV-Nantes, approval number: 024-A01573-44) and with the principles of the 1964 Declaration of Helsinki and its later amendments.
